Merchant Bankers Co., Ltd.
Biozipcode Co., Ltd. Notice regarding the status of international patent applications for antidiabetic drugs, etc.
Bio Zip Code Co., Ltd. (hereinafter referred to as “Bio Zip Code”) is an industry-academia collaboration with the National University Corporation Shiga University of Medical Science (hereinafter referred to as “Shiga University of Medical Science”) to completely cure diabetes. Merchant Bankers Co., Ltd. was established in January 2022 to promote research and development of therapeutic drugs.
Bio Zipcode has obtained the rights from Shiga University of Medical Science for two inventions related to the treatment of diabetes by Hideto Kojima (a domestic patent application was filed in October 2019; hereinafter referred to as the “inventions”). has been taken over.
This invention is an invention that forms the basis of Bio Zipcode’s business, and in October 2020, we filed an international application based on the PCT (Patent Cooperation Treaty) as follows. , Europe, China, Australia, and South Korea (procedures for transferring the international application from the international phase to the country where you wish to acquire the rights in order to undergo examination in the country where you wish to acquire the rights) This is to inform you that the national entry procedures (including the submission of translations) have been completed and the examination has started. As the examination in each country progresses, we can expect to obtain rights that correspond to the globalization of business.
· PCT/JP2020/039044 WO/2021/075535 Diabetes treatment targeting abnormal stem cells
· PCT/JP2020/039045 WO/2021/075536 Treatment of diabetes using a stem cell migration agent
Although this matter does not currently have any impact on our business performance for the fiscal year ending March 31, 2023, we will disclose it again if there is a business that will have a significant impact.
Details about this release: